Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
Clinical trial NCT04365868 · TERMINATED
Trial details
- NCT number
- NCT04365868
- Sponsor
- Galectin Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2025-03-11
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.